Prevalence of osteoporosis and its treatment among women ≥50 in NHANES: 1999-2018
Publication
, Conference
Mayer, SE; McGrath, LJ; Kim, M; McDermott, M; Brookhart, MA
Published in: PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
2021
Duke Scholars
Published In
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
EISSN
1099-1557
ISSN
1053-8569
Publication Date
2021
Volume
30
Start / End Page
28 / 28
Related Subject Headings
- Pharmacology & Pharmacy
- 4202 Epidemiology
- 3214 Pharmacology and pharmaceutical sciences
- 1117 Public Health and Health Services
- 1115 Pharmacology and Pharmaceutical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Mayer, S. E., McGrath, L. J., Kim, M., McDermott, M., & Brookhart, M. A. (2021). Prevalence of osteoporosis and its treatment among women ≥50 in NHANES: 1999-2018. In PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (Vol. 30, pp. 28–28).
Mayer, Sophie E., Leah J. McGrath, Min Kim, Michele McDermott, and M Alan Brookhart. “Prevalence of osteoporosis and its treatment among women ≥50 in NHANES: 1999-2018.” In PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 30:28–28, 2021.
Mayer SE, McGrath LJ, Kim M, McDermott M, Brookhart MA. Prevalence of osteoporosis and its treatment among women ≥50 in NHANES: 1999-2018. In: PHARMACOEPIDEMIOLOGY AND DRUG SAFETY. 2021. p. 28–28.
Mayer, Sophie E., et al. “Prevalence of osteoporosis and its treatment among women ≥50 in NHANES: 1999-2018.” PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, vol. 30, 2021, pp. 28–28.
Mayer SE, McGrath LJ, Kim M, McDermott M, Brookhart MA. Prevalence of osteoporosis and its treatment among women ≥50 in NHANES: 1999-2018. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY. 2021. p. 28–28.
Published In
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
EISSN
1099-1557
ISSN
1053-8569
Publication Date
2021
Volume
30
Start / End Page
28 / 28
Related Subject Headings
- Pharmacology & Pharmacy
- 4202 Epidemiology
- 3214 Pharmacology and pharmaceutical sciences
- 1117 Public Health and Health Services
- 1115 Pharmacology and Pharmaceutical Sciences